Alison Bauerlein is a director of Pear Therapeutics, Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Sight Sciences, Inc.
4 Apr 24
144
Sight Sciences, Inc.
3 Apr 24
4
Sight Sciences, Inc.
16 Feb 24
4
Sight Sciences, Inc.
11 May 23
3
Sight Sciences, Inc.
5 Apr 23
4
Pear Therapeutics, Inc.
17 Feb 23
4
Pear Therapeutics, Inc.
16 Jun 22
4
GELESIS HOLDINGS, INC.
9 May 22
3
GELESIS HOLDINGS, INC.
24 Jan 22
4
Pear Therapeutics, Inc.
10 Dec 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Apr 24 | SGHT Sight Sciences | Common Stock | Sell | Dispose S | No | No | 5.079 | 10,123 | 51.41 k | 426,248 |
14 Feb 24 | SGHT Sight Sciences | Common Stock | Grant | Dispose A | No | No | 0 | 315,421 | 0.00 | 436,371 |
9 May 23 | SGHT Sight Sciences | Common Stock | Grant | Acquire A | No | No | 0 | 103,000 | 0.00 | 0 |
9 May 23 | SGHT Sight Sciences | Stock Option Common Stock | Grant | Acquire A | No | No | 10.1 | 71,800 | 725.18 k | 71,800 |
15 Feb 23 | PEARQ Pear Therapeutics | Class A Common Stock | Grant | Acquire A | No | No | 0 | 71,428 | 0.00 | 71,428 |